Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Disease, 1st Edition
Author :
Paul J. Pockros
Date of Publication: 02/2013
Dr. Pockros has created a clinically focused issue based on the CONO 2012 meeting, whereby he was able to have those presenters write articles for his issue. Therefore, the content for HCV in this issue reflects the most current knowledge. The issue ...view more
Dr. Pockros has created a clinically focused issue based on the CONO 2012 meeting, whereby he was able to have those presenters write articles for his issue. Therefore, the content for HCV in this issue reflects the most current knowledge. The issue is focused on basic/current information, current therapy and special populations, triple and quad combination therapies in development, and an article on second generation protease inhibitors. The reader can expect that this issue will provide thorough clinical reviews on the most current therapeutic options for HCV.
Dr. Pockros has created a clinically focused issue based on the CONO 2012 meeting, whereby he was able to have those presenters write articles for his issue. Therefore, the content for HCV in this issue reflects the most current knowledge. The issue is focused on basic/current information, current therapy and special populations, triple and quad combination therapies in development, and an article on second generation protease inhibitors. The reader can expect that this issue will provide thorough clinical reviews on the most current therapeutic options for HCV.
Author Information
By Paul J. Pockros, MD, Scripps Research Institute, La Jolla, CA
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.uk.elsevierhealth.com/novel-and-combination-therapies-for-hepatitis-c-virus-an-issue-of-clinics-in-liver-disease-9781455771127.html85582Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Diseasehttps://www.uk.elsevierhealth.com/media/catalog/product/9/7/9781455771127_6.jpg59.8462.99GBPInStock/Medicine and Surgery/Gastroenterology & Hepatology/Books/Clinics Review Articles100425255039561283917453100005145120Dr. Pockros has created a clinically focused issue based on the CONO 2012 meeting, whereby he was able to have those presenters write articles for his issue. Therefore, the content for HCV in this issue reflects the most current knowledge. The issue is focused on basic/current information, current therapy and special populations, triple and quad combination therapies in development, and an article on second generation protease inhibitors. The reader can expect that this issue will provide thorough clinical reviews on the most current therapeutic options for HCV. Dr. Pockros has created a clinically focused issue based on the CONO 2012 meeting, whereby he was able to have those presenters write articles for his issue. Therefore, the content for HCV in this issue reflects the most current knowledge. The issue is focused on basic/current information, current therapy and special populations, triple and quad combination therapies in development, and an article on second generation protease inhibitors. The reader can expect that this issue will provide thorough clinical reviews on the most current therapeutic options for HCV.00add-to-cart97814557711272013ProfessionalBy Paul J. Pockros, MD20131Book152w x 229h (6.00" x 9.00")Elsevier025 Feb 2013PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG>Paul J. Pockros</STRONG>, MD, Scripps Research Institute, La Jolla, CAClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
